Researchers have created a one-step diagnosis of Hepatitis C virus involving just the subject’s urine sample. Precious diagnostic methods could involve a blood test and two separate labs for the subsequent test. This new technique would increase awareness and successful detection of this virus at early stages.
According to the World Health Organization, somewhere between 130 and 150 million people around the globe suffer from chronic hepatitis C infection. As the virus is usually asymptomatic it can go undetected in its early stages, giving rise to complications such as liver damage and cirrhosis. The previous detection method first checked the blood sample for signs of an immune response to the virus, specifically anti-hepatitis C antibodies. Confirmation and presence of these antibodies isn’t enough to be sure as those affected before, will have killed off the viruses but would still test positive.
The second stage of the diagnosis would entail a nucleic acid test for the hepatitis C virus, is needed to ascertain whether the infection is still active. With the cost of US$200 for this stage alone, most countries can’t afford this test. The new technique by researchers at the University of California Irvine’s School of Medicine is a one-step approach that allows the virus’ antigens to be detected in a urine sample instead.
“Our novel HCV (hepatitis C virus) antigen test system has significantly improved sensitivity and specificity over current tests,” says Dr Ke-Qin Hu, professor of gastroenterology and hepatology at University of California Irvine School of Medicine. “Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection.”
“The ability to detect infection using urine rather than blood avoids needlestick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale,” Hu says.
[adinserter block=”7″]
Author: Technology Blog





